首页> 外国专利> METHOD FOR PRODUCING ACTIVE INGREDIENT FOR RIVASTIGMINE FREE BASE TRANSDERMAL PATCH AND RIVASTIGMINE FREE BASE TRANSDERMAL PATCH COMPRISING THE SAME

METHOD FOR PRODUCING ACTIVE INGREDIENT FOR RIVASTIGMINE FREE BASE TRANSDERMAL PATCH AND RIVASTIGMINE FREE BASE TRANSDERMAL PATCH COMPRISING THE SAME

机译:制备含有相同成分的利维斯丁碱游离基皮肤斑块和利伐他汀无碱皮肤基斑的活性成分的方法

摘要

The present invention provides a method for producing an active ingredient for a rivastigmine free base transdermal patch having preparing a rivastigmine free base; and adding an acidic substance to the rivastigmine free base and subjecting the acidic substance and the rivastigmine free base to a mixed reaction to form a mixture having a pH value from 6.0 to 8.5 as the active ingredient; and a rivastigmine free base transdermal patch having a drug layer comprising the active ingredient. The rivastigmine free base transdermal patch has a stable transdermal transmission time equal to or longer than 48 hours and equal to or less than 168 hours. The active ingredient produced by the method and the transdermal patch having the active ingredient allow effective and smooth release of rivastigmine free base and prolongs the release time to meet the clinical application needs.
机译:本发明提供了一种制备具有卡巴拉汀游离碱的卡巴拉汀游离碱透皮贴剂的活性成分的方法。向所述卡巴拉汀游离碱中加入酸性物质,使该酸性物质与卡巴拉汀游离碱进行混合反应,形成pH值为6.0〜8.5的混合物作为有效成分。利凡斯的明游离碱透皮贴剂具有包含活性成分的药物层。利凡斯的明游离碱透皮贴剂具有等于或大于48小时且等于或小于168小时的稳定透皮传递时间。通过该方法生产的活性成分和具有该活性成分的透皮贴剂能够有效且平滑地释放卡巴拉汀游离碱并延长释放时间以满足临床应用需求。

著录项

  • 公开/公告号US2019185421A1

    专利类型

  • 公开/公告日2019-06-20

    原文格式PDF

  • 申请/专利权人 TSUNG-MIN HSU;

    申请/专利号US201715842117

  • 发明设计人 TSUNG-MIN HSU;

    申请日2017-12-14

  • 分类号C07C269/08;A61K9/70;A61K31/27;A61P25/28;C07C271/44;

  • 国家 US

  • 入库时间 2022-08-21 12:10:27

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号